Chemotherapy before surgery for head and neck cancer
Treatments studied
Part of Cancer, Ear, nose & throat, Lungs & breathing, Mouth & dental clinical trials.
This trial tests whether taking capecitabine (a chemotherapy pill) before surgery improves outcomes for patients with a certain type of head and neck cancer. The goal is to see if this approach can help shrink tumors and make surgery more effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have head and neck cancer that is not related to HPV infection.
- Your cancer has not spread to other parts of the body.
- You have not had any previous treatment for this cancer.
- You are generally healthy (able to care for yourself) and can undergo surgery.
- You are not pregnant or breastfeeding, and if you are a man, you agree to use contraception or remain abstinent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether taking capecitabine pills on a steady, low schedule after standard treatment can help keep locally advanced head and neck squamous cell cancer from coming back or spreading. You may be eligible if your cancer is stage III–IV and you have finished certain radiation/chemo treatments on time, without current spread.
This trial tests a combination of an immunotherapy drug (tirelizumab) with two chemotherapy drugs before surgery for head and neck cancer that has spread to lymph nodes. The goal is to shrink the tumor and improve treatment outcomes.
This trial tests giving a combination of two drugs (an immunotherapy drug called a PD-1 inhibitor and a targeted therapy called cetuximab) before surgery to shrink head and neck cancers. The goal is to see if this approach lowers the chance of the cancer coming back after surgery.
This trial tests giving a combination of chemotherapy and immunotherapy before surgery for head and neck cancer. The goal is to see if this approach can shrink the tumor and improve outcomes.
This trial tests whether giving tislelizumab (an immunotherapy) with chemotherapy before surgery works better than surgery alone for people with head and neck cancer that has not spread to lymph nodes. It's for cancers that can be removed with surgery, and the goal is to see if the pre-surgery treatment improves outcomes.
This trial tests whether giving immunotherapy along with chemotherapy before surgery can help treat locally advanced head and neck cancer that can be removed. The goal is to see if this combination shrinks tumors and improves outcomes.
Hear when a new Mouth Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.